Last reviewed · How we verify

NCT04960813

Kidpower Camp - Structured Games or Playgroup

Completed NA Results posted Last updated 30 April 2025
What this trial tests

NA trial testing Structured games in Anxiety Disorders in 158 participants. Completed in 1 March 2024.

Timeline
7 July 2021
Primary endpoint
1 March 2024
1 March 2024

Quick facts

Lead sponsorColumbia University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment158
Start date7 July 2021
Primary completion1 March 2024
Estimated completion1 March 2024
Sites4 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Columbia University

Who can join

Adults 48 Months to 71 Months, any sex, with Anxiety Disorders. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Change in Error Related Negativity (ERN) Primary · Pre-treatment (baseline) and post-treatment assessments (approximately 4-6 weeks)

The error-related negativity is a neurophysiological signal, measured via electroencephalogram (EEG), considered to reflect a dorsal anterior cingulate cortex (ACC) response to errors. For this study the ERN will be measured at electrode site FCz as the downward (negative voltage) deflection of the EEG signal that occurs 50-100 msec after error commission on the Zoo Task. Scores are measured continuously (no established minimum or maximum) . Higher scores reflect greater neural capacity for effortful control.

GroupValue95% CI
Kidpower - Structured Games-0.169± 8.129
Kidpower - Playgroup-1.192± 10.194
Change in National Institutes of Health (NIH) Toolbox Effortful Control (EC) Composite Scale Primary · Pre-treatment (baseline) and post-treatment assessments (approximately 4-6 weeks)

The NIH Toolbox EC Composite Scale will be comprised of children's standardized scores reflecting accuracy and reaction time on two computerized tasks: the Flanker inhibitory control and attention task and the Dimensional Change Card Sort (DCCS) test of set-shifting function. An NIH Toolbox EC Composite score will be based on factor loadings for each task derived from a factor analysis of scores across both Toolbox tasks. Scores are measured continuously (no established minimum or maximum) . Higher scores reflect greater behavioral capacity for effortful control.

GroupValue95% CI
Kidpower - Structured Games.3265± .628
Kidpower - Playgroup.406± .5655
Change in Clinical Global Impressions -Severity and Improvement Scales Primary · Pre-treatment (baseline) and post-treatment assessments (approximately 4-6 weeks)

The Clinical Global Impressions (CGI) is an observer rated scale used to assess anxiety severity (CGI-S) and pre- to post-treatment improvement in anxiety (CGI-I). Ratings for both use a 7-point scale, from 1 "normal" to 7 "among the most severely ill" for CGI-S and 1 ("very much improved") to 7 ("very much worse") for CGI-I.

CGI-S
GroupValue95% CI
Kidpower - Structured Games1.16± 0.93
Kidpower - Playgroup1.14± 0.98
CGI-I
GroupValue95% CI
Kidpower - Structured Games2.44± 0.76
Kidpower - Playgroup2.67± 0.87
Change in Anxiety Disorders Interview Schedule - Parent Version (ADIS-P) Secondary · Pre-treatment (baseline) and post-treatment assessments (approximately 4-6 weeks)

ADIS-P is a semi-structured clinical interview administered to parents about their child to assess Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) diagnoses where anxiety is a component. Severity of symptoms is rated by interviewers on a scale from none (=0) to very severe (=8), with clinician severity rating (CSR) ≥ 4 indicating presence of diagnosis. Changes in CSR of the primary (i.e., most severe at baseline) anxiety diagnosis from pre to post intervention will be assessed.

GroupValue95% CI
Kidpower - Structured Games2.04± 1.56
Kidpower - Playgroup1.94± 1.91
Change in Spence Preschool Anxiety Scale (Spence PAS) Secondary · Pre-treatment (baseline) up to post-treatment assessments (approximately 4-6 weeks)

The Spence PAS is a validated instrument for the measurement of parent report of anxiety symptoms in young children. Spence PAS scores will provide a continuous rating of anxiety symptoms from 0 to 112; high scores reflect greater anxiety.

GroupValue95% CI
Kidpower - Structured Games-10.4± 11.4
Kidpower - Playgroup-6.05± 14.9

Sponsor's own description

Clinically significant anxiety affects 20% of preschoolers and can become chronic, leading to depression, substance abuse, school-drop out and even suicide. To reduce anxiety and prevent its sequelae, clinically affected children must be effectively treated early. Available interventions for clinically anxious preschoolers are effective for some, but not all children, with as many as 50% of 4-7 year olds continuing to meet criteria for an anxiety disorder after treatment. This trial aims to help learn how Camp Kidpower, trainings using either structured games or a playgroup, may lower anxiety in preschool age children. Playing these games and learning that kids can do it, can teach kids how to keep going when they are feeling anxious. To find out if Kidpower works by helping kids stay in charge of their behaviors and emotions, the study will look at parts of the brain as well as behaviors related to effortful control and fear, before and after training. The study hypothesizes that Kidpower will produce greater increases in Error-related negativity (ERN), Interchannel Phase Synchrony (ICPS) and effortful control (EC) behaviors than in the Playgroup control.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Targeting neurobehavioral substrates of effortful control to reduce childhood anxiety The Camp Kidpower study protocol
    Ip KI, Rueppel M, Raguckas K, Lawler J, et al · · 2025 · DOI 10.21203/rs.3.rs-6342546/v1

Verify or expand the search:

Other recruiting trials for Anxiety Disorders

Currently open trials in the same condition.

Other Columbia University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04960813.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing